Search Results - "Gröne, E F"

Refine Results
  1. 1

    Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays by PROWATKE, I, DEVENS, F, BENNER, A, GRÖNE, E. F, MERTENS, D, GRÖNE, H.-I, LICHTER, P, IOOS, S

    Published in British journal of cancer (15-01-2007)
    “…To identify candidate genes relevant for prostate tumour prognosis and progression, we performed an exhaustive gene search in seven previously described…”
    Get full text
    Journal Article
  2. 2

    Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis by Crnković-Mertens, I, Wagener, N, Semzow, J, Gröne, E. F, Haferkamp, A, Hohenfellner, M, Butz, K, Hoppe-Seyler, F

    “…Cancer cells are typically characterized by apoptosis deficiency. In order to investigate a possible role for the anti-apoptotic livin gene in renal cell…”
    Get full text
    Journal Article
  3. 3

    Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney by WAGENER, N, CRNKOVIC-MERTENS, I, HAFERKAMP, A, AUTSCHBACH, F, HOHENFELLNER, M, HOPPE-SEYLER, F, VETTER, C, MACHER-GÖPPINGER, S, BEDKE, J, GRÖNE, E. F, ZENTGRAF, H, PRITSCH, M, HOPPE-SEYLER, K, BUSE, S

    Published in British journal of cancer (05-11-2007)
    “…The antiapoptotic Livin/ML-IAP gene has recently gained much attention as a potential new target for cancer therapy. Reports indicating that livin is expressed…”
    Get full text
    Journal Article
  4. 4

    Immunological evidence for hypochlorite-modified proteins in human kidney by Malle, E, Woenckhaus, C, Waeg, G, Esterbauer, H, Grone, EF, Grone, HJ

    Published in The American journal of pathology (01-02-1997)
    “…Oxygen radicals and oxidatively modified proteins seem to participate in degenerative vascular and inflammatory diseases. Factors that contribute to the…”
    Get full text
    Journal Article
  5. 5

    Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney : Localization and [125I]VEGF binding sites by SIMON, M, RÖCKL, W, HORNIG, C, GRÖNE, E. F, THEIS, H, WEICH, H. A, FUCHS, E, YAYON, A, GRÖNE, H.-J

    “…Vascular endothelial growth factor (VEGF) has an important function in renal vascular ontogenesis and is constitutively expressed in podocytes of the adult…”
    Get full text
    Journal Article
  6. 6

    Compartment specific expression of dendritic cell markers in human glomerulonephritis by Segerer, S., Heller, F., Lindenmeyer, M.T., Schmid, H., Cohen, C.D., Draganovici, D., Mandelbaum, J., Nelson, P.J., Gröne, H.-J., Gröne, E.F., Figel, A.-M., Nössner, E., Schlöndorff, D.

    Published in Kidney international (01-07-2008)
    “…Macrophages and dendritic cells are heterogenous and highly plastic bone marrow-derived cells that play major roles in renal diseases. We characterized these…”
    Get full text
    Journal Article
  7. 7

    Expression of vascular endothelial growth factor in renal vascular disease and renal allografts by Gröne, H J, Simon, M, Gröne, E F

    Published in The Journal of pathology (01-11-1995)
    “…Vascular endothelial growth factor (VEGF) is a dimeric glycoprotein that exerts a proliferative effect specifically on endothelial cells. VEGF can increase…”
    Get more information
    Journal Article
  8. 8

    The role of lipids in nephrosclerosis and glomerulosclerosis by Gröne, E F, Walli, A K, Gröne, H J, Miller, B, Seidel, D

    Published in Atherosclerosis (01-05-1994)
    “…Hyperlipidemia and lipoprotein abnormalities are often encountered in patients with nephrotic syndrome or chronic renal disease and also in those undergoing…”
    Get more information
    Journal Article
  9. 9

    Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment by Gröne, Hermann‐Josef, Weber, Christian, Weber, Kim S. C., Gröne, Elisabeth F., Rabelink, Ton, Klier, Christiane M., Wells, Timothy N. C., Proudfoot, Amanda E., Schlondorff, Detlef, Nelson, Peter J.

    Published in The FASEB journal (01-08-1999)
    “…ABSTRACTChemokines are thought to contribute to the cellular infiltrate characteristic of renal transplant rejection. We show that Met‐RANTES, a chemokine…”
    Get full text
    Journal Article
  10. 10

    Oxidant stress in hyperlipidemia-induced renal damage by Scheuer, H, Gwinner, W, Hohbach, J, Gröne, E F, Brandes, R P, Malle, E, Olbricht, C J, Walli, A K, Gröne, H J

    “…Hyperlipoproteinemia can aggravate glomerulosclerosis and chronic tubulointerstitial (ti) damage in kidneys without primary immunologic disease. We evaluated…”
    Get more information
    Journal Article
  11. 11

    Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins by Malle, E, Waeg, G, Schreiber, R, Gröne, E F, Sattler, W, Gröne, H J

    Published in European journal of biochemistry (01-07-2000)
    “…The 'oxidation theory' of atherosclerosis proposes that oxidation of low density lipoprotein (LDL) contributes to atherogenesis. Although the precise…”
    Get full text
    Journal Article
  12. 12

    Actions of lipoproteins in cultured human mesangial cells: modulation by mitogenic vasoconstrictors by Gröne, E F, Abboud, H E, Höhne, M, Walli, A K, Gröne, H J, Stüker, D, Robenek, H, Wieland, E, Seidel, D

    Published in The American journal of physiology (01-10-1992)
    “…Recent studies have suggested that hypercholesterolemia may aggravate glomerulosclerosis. Mesangial cells actively participate in this process. To elucidate…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: a nonimmunologic influence on alloreactivity by Stojanovic, T, Gröne, H J, Gieseler, R K, Klanke, B, Schlemminger, R, Tsikas, D, Gröne, E F

    Published in Laboratory investigation (01-02-1996)
    “…Clinical and experimental studies indicate that nonimmunologic factors may modulate the alloreactivity of a renal transplant. Nitric oxide (NO) is an essential…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Arterial hypertension and hyperlipidemia as determinants of glomerulosclerosis by Gröne, H J, Walli, A K, Gröne, E F

    Published in The Clinical Investigator (01-10-1993)
    “…Arterial hypertension is a dominant pathogenetic factor for glomerulosclerosis. Nevertheless metabolic factors such as hyper- or dyslipoproteinemia may…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Renaler Lupus erythematodes: Histopathologische Diagnose und Differenzialdiagnose by Gröne, E.F., Gröne, H.-J.

    Published in Der Nephrologe (01-11-2013)
    “…Zusammenfassung Dieser Artikel beschreibt die histopathologischen Veränderungen bei Lupusglomerulonephritis unter Einschluss von Differenzialdiagnosen. Die…”
    Get full text
    Journal Article
  20. 20